Dataset: Signatures of murine B-cell development implicate Yy1 as a regulator of the germinal center-specific program
Heirarchical development of B-cells involves the induction and supression of large sets of genes that provide the basis for...
Heirarchical development of B-cells involves the induction and supression of large sets of genes that provide the basis for differentiation and, ultimately, antibody production. We used microarrays to define comprehensive differentiation state-specific transcriptional signatures in order to gain insight into B-cell biology. In addition, we compared profiles of normal B-cells to those of murine lymphoma models that are putatively aligned with different states. B-cells of different differentiation states were purified from the bone marrow and spleen of mice use flow cytometry with antibodies specific for pre-defined markers of each differentiation state. Purified populations were then profiled using Affymetrix Mouse 430A2 gene expression microarrays. Tumors from Bcl6-trangenic mice, Bcl6/Myc dual-transgenic mice and p53/Lig4 double knock-out mice were also profiled using these microarrays in order to assess the similarities/differences between normal and malignant B-cells.
- Species:
- mouse
- Samples:
- 41
- Source:
- E-GEOD-26408
- PubMed:
- 21282644
- Updated:
- Dec.12, 2014
- Registered:
- Nov.24, 2014
Sample | ORGANISM PART | CELL TYPE | STRAIN OR LINE | GENOTYPE |
---|---|---|---|---|
GSM648154 | bone marrow | Purified Pro-B (B220-positive/CD43-high/IgM-negative) B-cells | 129 | Wild-type |
GSM648154 | bone marrow | Purified Pro-B (B220-positive/CD43-high/IgM-negative) B-cells | 129 | Wild-type |
GSM648156 | bone marrow | Purified Pro-B (B220-positive/CD43-high/IgM-negative) B-cells | B6 | Wild-type |
GSM648157 | bone marrow | Purified Pre-B (B220-positive/CD43-low/IgM-negative) B-cells | 129 | Wild-type |
GSM648157 | bone marrow | Purified Pre-B (B220-positive/CD43-low/IgM-negative) B-cells | 129 | Wild-type |
GSM648157 | bone marrow | Purified Pre-B (B220-positive/CD43-low/IgM-negative) B-cells | 129 | Wild-type |
GSM648160 | spleen | Purified Transitional (B220-positive/Cd93-positive) B-cells | 129 | Wild-type |
GSM648160 | spleen | Purified Transitional (B220-positive/Cd93-positive) B-cells | 129 | Wild-type |
GSM648160 | spleen | Purified Transitional (B220-positive/Cd93-positive) B-cells | 129 | Wild-type |
GSM648160 | spleen | Purified Transitional (B220-positive/Cd93-positive) B-cells | 129 | Wild-type |
GSM648164 | spleen | Purified Follicular (Cd19-positive/Cd21-intermediate/Cd23-high) B-cells | 129 | Wild-type |
GSM648164 | spleen | Purified Follicular (Cd19-positive/Cd21-intermediate/Cd23-high) B-cells | 129 | Wild-type |
GSM648164 | spleen | Purified Follicular (Cd19-positive/Cd21-intermediate/Cd23-high) B-cells | 129 | Wild-type |
GSM648167 | spleen | Purified Marginal Zone (Cd19-positive/Cd21-high/Cd23-low) B-cells | 129 | Wild-type |
GSM648167 | spleen | Purified Marginal Zone (Cd19-positive/Cd21-high/Cd23-low) B-cells | 129 | Wild-type |
GSM648167 | spleen | Purified Marginal Zone (Cd19-positive/Cd21-high/Cd23-low) B-cells | 129 | Wild-type |
GSM648170 | spleen | Purified Germinal Centre (B220-positive/PNA-high) B-cells | B6 | Wild-type |
GSM648170 | spleen | Purified Germinal Centre (B220-positive/PNA-high) B-cells | B6 | Wild-type |
GSM648170 | spleen | Purified Germinal Centre (B220-positive/PNA-high) B-cells | B6 | Wild-type |
GSM648170 | spleen | Purified Germinal Centre (B220-positive/PNA-high) B-cells | B6 | Wild-type |
GSM648170 | spleen | Purified Germinal Centre (B220-positive/PNA-high) B-cells | B6 | Wild-type |
GSM648175 | spleen | Purified Plasmablasts (B220-positive/Cd138-positive/Cd93-negative) | B6 | Wild-type |
GSM648175 | spleen | Purified Plasmablasts (B220-positive/Cd138-positive/Cd93-negative) | B6 | Wild-type |
GSM648175 | spleen | Purified Plasmablasts (B220-positive/Cd138-positive/Cd93-negative) | B6 | Wild-type |
GSM648175 | spleen | Purified Plasmablasts (B220-positive/Cd138-positive/Cd93-negative) | B6 | Wild-type |
GSM648179 | bone marrow | Purified Plasma cells (B220-low/Cd138-positive/Cd93-negative) | B6 | Wild-type |
GSM648179 | bone marrow | Purified Plasma cells (B220-low/Cd138-positive/Cd93-negative) | B6 | Wild-type |
GSM648179 | bone marrow | Purified Plasma cells (B220-low/Cd138-positive/Cd93-negative) | B6 | Wild-type |
GSM648182 | Tumor | Lymphoid tumor | Bcl6 transgenic (Catoretti et al., Cancer Cell 2005 | Bcl6 knock-in |
GSM648182 | Tumor | Lymphoid tumor | Bcl6 transgenic (Catoretti et al., Cancer Cell 2005 | Bcl6 knock-in |
GSM648182 | Tumor | Lymphoid tumor | Bcl6 transgenic (Catoretti et al., Cancer Cell 2005 | Bcl6 knock-in |
GSM648182 | Tumor | Lymphoid tumor | Bcl6 transgenic (Catoretti et al., Cancer Cell 2005 | Bcl6 knock-in |
GSM648186 | Tumor | Lymphoid tumor | Myc/Bcl6 dual-transgenic (Pasqualucci et al., Nat. Genet. 2008;40:108-112) | Bcl6/Myc dual-transgenic |
GSM648186 | Tumor | Lymphoid tumor | Myc/Bcl6 dual-transgenic (Pasqualucci et al., Nat. Genet. 2008;40:108-112) | Bcl6/Myc dual-transgenic |
GSM648186 | Tumor | Lymphoid tumor | Myc/Bcl6 dual-transgenic (Pasqualucci et al., Nat. Genet. 2008;40:108-112) | Bcl6/Myc dual-transgenic |
GSM648189 | Tumor | Lymphoid tumor | Lig4/P53 KO (Frank et al., Mol. Cell 2000;5:993-1002) | Lig4/p53 double knock-out |
GSM648189 | Tumor | Lymphoid tumor | Lig4/P53 KO (Frank et al., Mol. Cell 2000;5:993-1002) | Lig4/p53 double knock-out |
GSM648189 | Tumor | Lymphoid tumor | Lig4/P53 KO (Frank et al., Mol. Cell 2000;5:993-1002) | Lig4/p53 double knock-out |
GSM648189 | Tumor | Lymphoid tumor | Lig4/P53 KO (Frank et al., Mol. Cell 2000;5:993-1002) | Lig4/p53 double knock-out |
GSM648189 | Tumor | Lymphoid tumor | Lig4/P53 KO (Frank et al., Mol. Cell 2000;5:993-1002) | Lig4/p53 double knock-out |
GSM648189 | Tumor | Lymphoid tumor | Lig4/P53 KO (Frank et al., Mol. Cell 2000;5:993-1002) | Lig4/p53 double knock-out |